The market for computed tomography devices in Thailand is directly influenced by the country's demographic shift and the increasing incidences of non-communicable diseases (NCDs). As the population ages, conditions such as cardiovascular and neurological disorders have become leading causes of morbidity and mortality, driving the demand for sophisticated diagnostic imaging. CT is now a cornerstone of cardiovascular care, with CT angiography being instrumental in detecting coronary artery disease and assessing cardiac health. Similarly, in neurology, CT provides rapid, life-saving insights for patients presenting with suspected stroke or brain hemorrhages, where timely diagnosis is critical for a favorable outcome. Beyond NCDs, the technology's application in oncology is paramount. With cancer as a prominent health issue, CT is essential for the early identification, precise staging, and continuous monitoring of tumors in organs like the lungs, liver, and colon, thereby enhancing treatment planning and patient care. The versatility of CT also extends to trauma cases, where it offers a comprehensive view of internal injuries, and in the management of infectious diseases like tuberculosis, providing detailed imagery of lung abnormalities. The expanding scope of CT's clinical utility reflects its indispensable role in supporting the healthcare system's capacity to manage a broad spectrum of complex health challenges. Thus, the market growth is intrinsically linked to Thailand's need for advanced diagnostic tools to combat its evolving disease landscape. CT technology is essential in improving the precision of diagnosis and care across a wide range of medical conditions.